Chen Chen

Chen represents public and private life sciences companies in complex licensing, collaboration and corporate partnering transactions. She advises clients on strategic collaborations, license and option agreements, venture-backed NewCo transactions, and co-development, co-commercialization and profit-sharing arrangements, including cross-border and territory-specific transactions. Chen holds a Ph.D. from Stanford University. Drawing on her scientific background, Chen works with clients across a range of therapeutic modalities and technologies and brings a sophisticated understanding of the science underlying their businesses to the structuring and negotiation of transactions involving complex intellectual property. She also works closely with life sciences companies from their earliest stages, advising on foundational in-licenses, platform validation and feasibility studies, research and development collaborations, and discovery-stage partnerships. Chen also counsels clients on day-to-day operational matters, including manufacturing and supply, sponsored research, clinical trials and vendor services.